Simply inject when you remember and adjust your schedule
Treatments with any of the multi-agonists significantly reduced body weight from 24- to 72-h relative to control PWA animals, while GLP1 decreased body weight only from 24- to 48-h
47 In June 2025, the European Medicines Agency recommended cessation of semaglutide use if a patient is newly diagnosed with NAION
Herb-Roasted Holiday Chicken with Citrus & Rosemary (Festive, balanced main dish) Elegant, fragrant, and simple, perfect for Christmas Eve or Christmas Day
And while most of the current GLP-1 research in addiction focuses on alcohol use disorder, there is also research underway or in progress related to: Nicotine dependence Stimulants (such as cocaine and amphetamines) Opioids (mainly in early and preclinical stages) What Early GLP-1 Addiction Studies Show Clinically What stands out to me clinically is the consistency of the signal emerging around GLP-1 medications and addiction-related cravings
For most people, the result is some temporary nausea, a bit of bloating, or a few days of looser stools